(AOF) – Spineway totals a turnover of 2.1 million euros for the 3rd quarter of 2023, compared to 2.24 million in 2022, a drop of 8%. This brings 9-month activity to 7.5 million euros, an increase of 40% compared to last year. The specialist in ranges of implants and innovative surgical ancillaries (instruments) intended to treat severe spinal pathologies specifies that the increase in sales over 9 months is driven by the sales of Spine Innovations, integrated in July 2022.
The turnover for the 3rd quarter is “mechanically marked by a less favorable scope effect” underlines the group.
© AOF
Legal notice
The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights held by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, rebroadcast, translation, commercial exploitation or not, creation of a hypertext link or reuse in any manner whatsoever of this information is subject to the prior written agreement of OPTION FINANCE SAS and its contributors. AOF can be reached at the following address [email protected] OPTION FINANCE SAS collects its data from the sources it considers the safest. However, subject to gross negligence, OPTION FINANCES SAS and its contributors do not in any way guarantee the absence of errors and defects, even hidden ones, nor the exhaustive nature or lack of conformity for any use of this data and of OPTION FINANCE SAS or one of its contributors, and cannot be held responsible for delays or interruptions which could affect access to the latter. The user of the OPTION FINANCE SAS service will use AOF data at their own risk and must hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.
Receive our latest news
Every morning, the information to remember about financial markets.
2023-10-13 16:27:30
#Spineway #drop #quarterly #turnover
